Literature DB >> 10067920

Improved motor outcome in response to magnesium therapy received up to 24 hours after traumatic diffuse axonal brain injury in rats.

D L Heath1, R Vink.   

Abstract

OBJECT: The goal of this study was to establish the therapeutic window during which delayed therapy with MgSO4 improves neurological motor outcome in rats that have suffered severe traumatic axonal brain injury.
METHODS: Severe brain injury was induced in male Sprague-Dawley rats by using the impact-acceleration model of severe traumatic diffuse axonal brain injury. Injured animals were subsequently treated with MgSO4 (750 micromol/kg) infused intramuscularly at 30 minutes or at 8, 12, or 24 hours after trauma and were tested for neurological motor outcome during the following week by using the rotarod test. Injured untreated (control) animals demonstrated highly significant (p < 0.001) neurological motor deficits that were sustained over the 1-week assessment period. Animals treated with MgSO4 at 30 minutes or at 8 or 12 hours postinjury demonstrated significantly improved motor outcomes compared with untreated control animals at all time points (0.001 < p < 0.05). Animals treated with MgSO4 at 24 hours had motor scores that were similar to those of untreated control animals early in the week, but demonstrated a significantly more rapid recovery in function and, by the end of the assessment period, they demonstrated significantly improved motor scores (p < 0.01). Repeated administration of MgSO4 over the 1-week observation period did not further improve outcome.
CONCLUSIONS: The present results demonstrate that Mg++ plays a neuroprotective role following severe diffuse traumatic axonal brain injury. Moreover, Mg++ therapy significantly improved motor outcome when administered up to 24 hours after injury, with early treatments providing the most significant benefit. Repeated administration beyond 24 hours postinjury did not provide additional neuroprotection.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10067920     DOI: 10.3171/jns.1999.90.3.0504

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  17 in total

1.  When basic research doesn't translate to the bedside--lessons from the magnesium brain trauma study.

Authors:  John W Miller; Raimondo D'Ambrosio
Journal:  Epilepsy Curr       Date:  2007 Sep-Oct       Impact factor: 7.500

2.  Activated protein C analog promotes neurogenesis and improves neurological outcome after focal ischemic stroke in mice via protease activated receptor 1.

Authors:  Yaoming Wang; Zhen Zhao; Nienwen Chow; Tracy Ali; John H Griffin; Berislav V Zlokovic
Journal:  Brain Res       Date:  2013-02-21       Impact factor: 3.252

3.  Elucidating the severity of preclinical traumatic brain injury models: a role for functional assessment?

Authors:  Ryan C Turner; Reyna L VanGilder; Zachary J Naser; Brandon P Lucke-Wold; Julian E Bailes; Rae R Matsumoto; Jason D Huber; Charles L Rosen
Journal:  Neurosurgery       Date:  2014-04       Impact factor: 4.654

Review 4.  Animal modelling of traumatic brain injury in preclinical drug development: where do we go from here?

Authors:  Niklas Marklund; Lars Hillered
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

5.  Material characterization and computer model simulation of low density polyurethane foam used in a rodent traumatic brain injury model.

Authors:  Liying Zhang; Manish Gurao; King H Yang; Albert I King
Journal:  J Neurosci Methods       Date:  2011-04-01       Impact factor: 2.390

Review 6.  Pharmacological treatment of traumatic brain injury: a review of agents in development.

Authors:  J Hatton
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

7.  Quantitative relationship between axonal injury and mechanical response in a rodent head impact acceleration model.

Authors:  Yan Li; Liying Zhang; Srinivasu Kallakuri; Runzhou Zhou; John M Cavanaugh
Journal:  J Neurotrauma       Date:  2011-09-06       Impact factor: 5.269

Review 8.  Use of magnesium in traumatic brain injury.

Authors:  Ananda P Sen; Anil Gulati
Journal:  Neurotherapeutics       Date:  2010-01       Impact factor: 7.620

9.  Activated protein C promotes neovascularization and neurogenesis in postischemic brain via protease-activated receptor 1.

Authors:  Meenakshisundaram Thiyagarajan; José A Fernández; Steven M Lane; John H Griffin; Berislav V Zlokovic
Journal:  J Neurosci       Date:  2008-11-26       Impact factor: 6.167

10.  VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia.

Authors:  Yunjuan Sun; Kunlin Jin; Lin Xie; Jocelyn Childs; Xiao Ou Mao; Anna Logvinova; David A Greenberg
Journal:  J Clin Invest       Date:  2003-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.